Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medlive Technology CoHKSE:02192 +0.90%90 Current Ratio is 19.09 as of Dec. 2025, which is 5% below its 10-year median of 20.06. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Medlive Technology Co ranks better than 98.53% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medlive Technology Co's current ratio for the quarter that ended in Dec. 2025 was 19.09.
Medlive Technology Co has a current ratio of 19.09. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Medlive Technology Co's Current Ratio or its related term are showing as below:
HKSE:02192'
s Current Ratio Range Over the Past 10 Years
Min: 1.86 Med: 20.06 Max: 35.45
Current: 19.09
During the past 8 years, Medlive Technology Co's highest Current Ratio was 35.45. The lowest was 1.86. And the median was 20.06.
HKSE:02192's Current Ratio is ranked better than 98.53% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs HKSE:02192: 19.09
Medlive Technology Co (HKSE:02192) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medlive Technology Co Current Ratio Related Terms
Medlive Technology Co Current Ratio Historical Data
* Premium members only.
The historical data trend for Medlive Technology Co's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02192 vs VEEV, BTSG, HQY: Current Ratio Comparison
For the Health Information Services subindustry, Medlive Technology Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) has a Current Ratio of 19.09 as of Dec. 2025. This is near median its historical median of 20.06. Over the past decade, Medlive Technology Co's Current Ratio has ranged from 1.86 to 35.45. According to the industry distribution chart, Medlive Technology Co ranks #10 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 1.5%.
Is Medlive Technology Co's Current Ratio too high?
Medlive Technology Co's current Current Ratio of 19.09 is near median its 10-year median of 20.06. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 35.45. The Healthcare Providers & Services industry median Current Ratio is 1.47. Medlive Technology Co's value of 19.09 is 1198.6% above this industry median. Based on the distribution chart, Medlive Technology Co ranks #10 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #10 out of 678 companies for Current Ratio. This places Medlive Technology Co in the top 2% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.47. Medlive Technology Co's value of 19.09 is 1198.6% above this benchmark. Historically, Medlive Technology Co's own Current Ratio has ranged from 1.86 to 35.45 over the past decade. While the company's 10-year median is 20.06 vs. the industry median of 1.47, Medlive Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current Current Ratio of 19.09 is 1198.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current Current Ratio is 19.09, which is near median its own 10-year median of 20.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.87 — trading 47.4% below its estimated fair value. The current Current Ratio is 19.09, which is near median its 10-year median of 20.06 and 1198.6% above the Healthcare Providers & Services industry median of 1.47. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current Current Ratio is 19.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?
Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued.
The current stock price of HK$7.87 is trading 47.4% below its estimated GF Value™ of HK$14.95.
GuruFocus considers Medlive Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02192:
Current Ratio: 19.09 (near median its 10-year median of 20.06)
GF Value™: HK$14.95 vs. price of HK$7.87 (47.4% below fair value)
Industry Position: 1198.6% above the Healthcare Providers & Services median (#10 of 678)
No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score
Get the complete analysis for HKSE:02192
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02192 has been successfully added to your 
